The panTB-HM clinical trial has begun patient recruitment in South Africa, with first patient dosed on 28 July 2023. This trial is a historic milestone in the quest to revolutionise tuberculosis (TB) treatment and improve outcomes for all TB patients. The panTB-HM trial addresses the World Health Organisation (WHO) target profile for new TB regimens […]
